Wie läuft der Ionophorese-Prozess ab?

Ionophoresis constitutes a specialized electrotherapeutic modality within the broader spectrum of physical therapy, leveraging controlled direct current to facilitate the transdermal delivery of pharmaceutical agents directly to the site of pathology. Unlike conventional galvanization, this procedure incorporates the application of medicated substances—such as ointments, aqueous solutions, or gels—with documented anti-inflammatory and analgesic properties. Its efficacy is contingent upon multiple variables, including current intensity, duration of exposure, and patient-specific physiological characteristics, such as adipose tissue percentage, body mass, epidermal hydration levels, and hair density at the application site. A critical determinant is the drug’s capacity for electrolytic dissociation, as only ionized active ingredients are propelled into deeper tissue layers under the influence of the electric field. This approach circumvents the gastrointestinal tract, thereby mitigating the risk of mucosal irritation while accelerating the bioavailability of active compounds and expediting the onset of tissue recovery. The procedure itself demands meticulous preparation: the skin must be disinfected and, if necessary, depilated to prevent impedance of electrical conductivity and drug absorption. The medication is applied to a moistened gauze pad, followed by the placement of an electrode with polarity corresponding to the electrical charge of the drug molecules; incorrect selection would preclude intracellular transport. The gauze is further insulated with a waterproof barrier (e.g., oilcloth or lignin), and the assembly is secured with a bandage (excluding the back region). Upon activating the device, the practitioner adjusts the optimal dosage and treatment duration. Post-procedure, the treated area must be shielded from external contaminants.

The operational framework of ionophoresis is characterized by a dual mechanistic paradigm, wherein the primary—and most clinically significant—effect is contingent upon the pharmacological profile of the agent delivered via the controlled application of direct current. Among the most frequently administered therapeutic substances are analgesic compounds formulated as ointments or gels with optimized rheological properties. The galvanic current facilitates enhanced transdermal penetration of active pharmaceutical ingredients, thereby augmenting therapeutic precision and ensuring targeted relief within the affected anatomical region. Chronic oral administration of pain-relieving medications is associated with progressive mucosal damage within the gastrointestinal tract, as well as hepatic and renal metabolic strain. Ionophoresis circumvents these risks by bypassing the digestive system entirely, thereby mitigating potential systemic adverse effects while preserving overall patient well-being. However, the procedure’s therapeutic utility extends beyond mere drug delivery—the direct physiological impact of the applied direct current constitutes a critical component of its efficacy. The clinical benefits of galvanic current-based electrotherapy have been extensively documented in peer-reviewed literature, with its therapeutic spectrum transcending simple analgesia. Key physiological outcomes include: enhanced microcirculatory perfusion via capillary vasodilation, accelerated clearance of metabolic byproducts from the treated area, optimization of cellular respiration and tissue oxygenation, attenuation of neuronal hyperexcitability within the application site, and promotion of regenerative processes at both cellular and tissue levels. These cumulative effects contribute to expedited recovery timelines and the restoration of systemic homeostasis.

The practical implementation of iontophoresis varies depending on the specific nature of the treatment being administered. The most commonly encountered method, referred to as *stable iontophoresis*, involves the fixed positioning of electrodes through which a direct current of consistent intensity flows. This therapeutic modality is employed in the management of post-traumatic scarring, chronic inflammatory conditions affecting diverse anatomical structures—ranging from the laryngeal mucosa to muscle tendon sheaths and the tissues of the middle ear. Additionally, it effectively supports the treatment of musculoskeletal pain syndromes, post-traumatic conditions, neuralgias of varied etiology, muscle contractures, and delayed bone union. Though less frequently, iontophoresis is also utilized in cosmetic procedures, where its application targets the reduction of acne lesions, improvement of skin firmness, regulation of excessive sweating, attenuation of wrinkles, and elimination of hyperpigmentation. In the context of aesthetic treatments based on galvanic current, the term *labile iontophoresis* is used, wherein electrodes are systematically repositioned to elicit a more generalized systemic response rather than strictly localized therapeutic effects.

It is imperative to emphasize that attempting to perform iontophoresis procedures independently constitutes a grave error with potential severe health consequences! Any form of physical stimulation may induce adverse reactions within the human body and, in extreme cases, lead to permanent impairment. For this reason, therapy based on the medicinal properties of direct electric current must be administered exclusively by qualified medical professionals—primarily by licensed physiotherapists whose expertise ensures both risk mitigation and optimization of therapeutic outcomes. The dosage parameters, including current intensity and session duration, are contingent upon a multitude of patient-specific factors. The most critical considerations include individual sensitivity to electrical stimuli, percentage of body fat composition, biological age, the nature of the diagnosed medical condition, and the patient’s prior treatment history. The selection of current intensity is typically guided by the patient’s subjective perception, although certain therapeutic protocols establish an upper safety threshold of 0.2 milliamperes per square centimeter of the active electrode surface. The standard treatment duration ranges from 15 to 30 minutes, a timeframe dictated by the pharmacokinetics of drug absorption—a process that reaches peak efficiency several minutes after initiation. The complete therapeutic cycle generally comprises 10 to 25 sessions, adjusted according to the clinical response dynamics. While iontophoresis is regarded as a high-safety-profile modality (provided strict adherence to occupational health and safety regulations as well as standardized procedural guidelines), there exists a catalog of absolute contraindications that categorically preclude its use. These include peripheral sensory impairments or complete loss of sensation, acute phases of most systemic diseases, febrile or subfebrile states, active dermatological lesions such as ulcers or eczema, vascular pathologies (including advanced atherosclerosis and anemia), open postoperative or traumatic wounds, and spastic paralysis of musculoskeletal components. Additionally, the therapy is contraindicated in pregnant women, patients with diagnosed psychiatric disorders, individuals with joint endoprostheses, and those with implanted pacemakers or other electrical medical devices.